Accelerating Medicines Partnership

GPTKB entity

Statements (56)
Predicate Object
gptkbp:instanceOf gptkb:Research_Institute
gptkbp:aimsTo improve patient outcomes
accelerate drug development
streamline regulatory processes
enhance collaboration among stakeholders
identify new drug targets
reduce drug development costs
validate biomarkers
gptkbp:collaboratesWith gptkb:FDA
academic institutions
gptkbp:encourages patient involvement
innovation in medicine
gptkbp:enhances biomarker_discovery
gptkbp:establishedIn 2014
gptkbp:facilitates data integration
gptkbp:focusesOn precision medicine
gptkbp:hasCollaboratedWith other research initiatives
gptkbp:hasGoals reducing time to market
improving drug efficacy
gptkbp:hasImpactOn drug discovery process
gptkbp:hasPart Alzheimer's Disease Project
Type 2 Diabetes Project
Rheumatoid_Arthritis_Project
https://www.w3.org/2000/01/rdf-schema#label Accelerating Medicines Partnership
gptkbp:includes pharmaceutical companies
gptkbp:involves public-private partnerships
biopharmaceutical industry
gptkbp:isBasedOn gptkb:United_States
gptkbp:isDocumentedIn annual reports
conference proceedings
research articles
scientific publications
clinical trial registries
gptkbp:isEvaluatedBy independent reviewers
government oversight bodies
gptkbp:isFundedBy government agencies
non-profit organizations
gptkbp:isInfluencedBy advancements in technology
scientific discoveries
patient needs
gptkbp:isPartOf larger healthcare initiatives
gptkbp:isPromotedBy health advocacy groups
gptkbp:isRecognizedBy scientific community
gptkbp:isSupportedBy research institutions
healthcare_organizations
gptkbp:launched gptkb:National_Institutes_of_Health
gptkbp:promotes collaborative research
translational research
gptkbp:provides research funding
data sharing platform
gptkbp:supports clinical trials
gptkbp:targets Alzheimer's disease
rheumatoid arthritis
type 2 diabetes
gptkbp:utilizes clinical data
genomic data